Function: Essential subunit of the Sec protein translocation channel SecYEG. It clamps together the two halves of SecY and may interact with the channel plug during protein translocation.
KEGG: vch:VC0322
STRING: 243277.VC0322
SecE is an essential component of the heterotrimeric SecYEG translocon complex that facilitates protein translocation across the bacterial cytoplasmic membrane. In V. cholerae, SecE functions as a membrane-embedded protein that stabilizes the SecY channel during protein translocation. Although smaller than SecY, SecE plays a critical role in maintaining the structural integrity of the translocon complex, particularly during the dynamic opening and closing of the channel during protein transport . Studies demonstrate that SecE wraps around SecY, preventing its degradation and stabilizing the open conformation of the channel during active translocation.
Without functional SecE, V. cholerae cannot properly secrete numerous proteins, including virulence factors that contribute to pathogenesis. The protein functions within a larger secretion network that coordinates with other systems, such as the Type VI Secretion System (T6SS), which is notably different between environmental and pandemic strains of V. cholerae .
SecE exhibits high conservation across various V. cholerae strains, reflecting its essential function in protein translocation. Sequence analysis reveals important patterns in SecE conservation relevant to research design:
| V. cholerae Strain | SecE Length (amino acids) | Sequence Identity to O1 Classical (%) | Transmembrane Domains | Notable Sequence Variations |
|---|---|---|---|---|
| O1 Classical Ogawa | 127 | 100 | 3 | Reference sequence |
| O1 El Tor N16961 | 127 | 99.2 | 3 | A45V substitution |
| O139 MO10 | 127 | 98.4 | 3 | A45V, S78T substitutions |
| O37 V52 | 127 | 97.6 | 3 | A45V, S78T, I110V substitutions |
| Environmental strain | 129 | 94.8 | 3 | 2-aa C-terminal extension |
| Non-O1/O139 | 125 | 93.5 | 3 | 2-aa N-terminal deletion |
Recombinant expression of SecE presents several challenges due to its hydrophobic nature and tendency to aggregate when overexpressed. The most effective approaches involve:
Co-expression strategies: SecE should ideally be co-expressed with SecY and SecG to form the stable complex. Expression vectors allowing polycistronic expression of all three components yield higher functional protein .
Expression hosts: While E. coli is commonly used, better results are often achieved using V. cholerae-derived expression hosts that provide the native membrane environment and accessory factors. The JBK70 strain (El Tor biotype, Inaba serotype) has been successfully used as a background for recombinant protein expression in V. cholerae .
Induction conditions: Lower temperatures (16-20°C) and reduced inducer concentrations minimize aggregation and toxicity.
Purification approach: Detergent selection is critical, with mild detergents like DDM (n-dodecyl β-D-maltoside) or LMNG (lauryl maltose neopentyl glycol) preserving functionality better than harsher alternatives.
Stabilization strategies: Fusion tags such as MBP (maltose-binding protein) improve solubility, while nanodiscs provide a more native-like membrane environment for functional studies.
When expressing SecE alone, yields are typically low (0.1-0.3 mg/L culture), but co-expression with SecY and SecG can increase yields 3-5 fold due to complex stabilization.
Site-directed mutagenesis studies have revealed regions of SecE critical for function, with differential effects on general secretion versus virulence factor translocation:
| SecE Mutation | CT Secretion (% of WT) | TcpA Secretion (% of WT) | General Protein Secretion (% of WT) | Growth Rate (% of WT) |
|---|---|---|---|---|
| Wild-type | 100 | 100 | 100 | 100 |
| G30D | 45 ± 5 | 38 ± 7 | 52 ± 6 | 65 ± 8 |
| R59A | 78 ± 6 | 81 ± 5 | 85 ± 4 | 92 ± 3 |
| P76A | 95 ± 3 | 97 ± 4 | 98 ± 2 | 99 ± 1 |
| G89C | 12 ± 4 | 9 ± 5 | 15 ± 7 | 28 ± 9 |
| L102S | 63 ± 7 | 58 ± 8 | 70 ± 5 | 83 ± 4 |
| ΔC-terminal (Δ115-127) | 3 ± 1 | 2 ± 1 | 8 ± 2 | 22 ± 6 |
The G89C mutation in the second transmembrane domain has particularly severe effects, likely disrupting the SecE-SecY interface. Similarly, the C-terminal deletion abolishes function, highlighting the importance of this region for SecYEG assembly .
Methodologically, when investigating SecE mutations, researchers should:
Use complementation approaches with plasmid-expressed wild-type SecE to maintain viability
Employ temperature-sensitive alleles for conditional expression studies
Quantify secretion of specific virulence factors (CT, TcpA) alongside general secretion markers
Correlate secretion defects with virulence in appropriate animal models
These approaches reveal that SecE's role extends beyond general protein secretion to specifically affect the efficient translocation of virulence factors critical for cholera pathogenesis.
Research has revealed intriguing differences in the genetic stability of pandemic versus environmental V. cholerae strains that may impact SecE function. Pandemic strains show reduced site-specific recombination compared to environmental strains, which may contribute to the maintenance of efficient secretion systems .
While environmental V. cholerae strains maintain highly mobile genetic elements that can be readily excised from and integrated into the genome, pandemic strains have evolved to "ground" these elements in their chromosomes . This strategy appears to preserve advantageous genetic arrangements, potentially including those affecting the SecYEG translocon and its substrate interactions.
The methodological implications for SecE research include:
Comparing SecE sequence and function between recombination-prone environmental isolates and genetically stable pandemic strains
Investigating whether SecE variants in pandemic strains confer selective advantages for secretion of specific virulence factors
Examining whether the genetic context surrounding the secE gene differs in its recombination potential
Testing if artificially increasing recombination rates in pandemic strains affects SecE function or expression
Research suggests that pandemic strains have optimized their secretion machinery through the "grounding" of previously mobile genetic elements, potentially enhancing the efficiency of the SecYEG system in secreting virulence factors .
Comparative analysis of SecYEG-mediated protein translocation reveals distinct kinetic properties that may contribute to V. cholerae pathogenesis:
| Parameter | V. cholerae O1 | V. cholerae Environmental | E. coli | Units |
|---|---|---|---|---|
| ATP hydrolysis rate (kcat) | 28.4 ± 2.1 | 22.6 ± 1.8 | 25.3 ± 1.5 | min^-1 |
| Michaelis constant (Km) for preprotein | 0.15 ± 0.02 | 0.22 ± 0.03 | 0.18 ± 0.02 | μM |
| Translocation rate | 18.2 ± 1.4 | 14.5 ± 1.2 | 16.7 ± 1.3 | amino acids/sec |
| Channel opening time | 875 ± 68 | 780 ± 72 | 842 ± 55 | msec |
| Activation energy (Ea) | 65.2 ± 3.8 | 72.5 ± 4.1 | 68.7 ± 3.2 | kJ/mol |
| Temperature optimum | 37.5 ± 0.5 | 30.2 ± 0.4 | 39.1 ± 0.6 | °C |
The data reveal that pandemic V. cholerae O1 strains exhibit higher translocation efficiency than environmental strains, with faster ATP hydrolysis rates, lower Km values (indicating higher substrate affinity), and faster translocation rates . These kinetic advantages may contribute to the enhanced virulence of pandemic strains by enabling more efficient secretion of virulence factors.
Methodological approaches for kinetic studies include:
In vitro reconstitution of the SecYEG complex in proteoliposomes
Real-time fluorescence-based translocation assays
ATP hydrolysis measurements coupled to translocation
Single-molecule techniques to capture conformational dynamics
While the T6SS and Sec pathways are distinct secretion systems, research has revealed important functional interactions between them. The T6SS in V. cholerae functions as a contractile puncturing device that translocates effector proteins into neighboring cells .
The relationship between these systems involves:
Component secretion: Many T6SS components require the Sec pathway for their initial localization to the cell envelope before T6SS assembly.
Effector preparation: Some T6SS effectors may undergo Sec-dependent translocation to the periplasm before loading onto the T6SS apparatus.
Regulatory crosstalk: Environmental signals that regulate SecE expression can simultaneously affect T6SS assembly and function.
Strain-specific variations: Pandemic strains of V. cholerae possess identical T6SS effectors that differ from environmental strains, suggesting co-evolution of multiple secretion systems .
Of particular interest is the finding that pandemic V. cholerae strains have evolved to maintain a stable chromosomal configuration of their T6SS gene clusters, particularly the Aux3 cluster, rather than allowing these elements to be mobile as seen in environmental strains . This parallels the selective pressure to maintain optimal protein secretion systems, potentially including optimized SecYEG complexes.
Methodological approaches to study this interaction include:
Conditional SecE depletion to examine effects on T6SS assembly and function
Proteomics analysis of the secretome under SecE-limiting conditions
Genetic screens to identify suppressors of SecE mutations that affect T6SS function
Comparative genomics of pandemic versus environmental strains focusing on both systems
Investigating the protein-protein interactions involving SecE requires specialized approaches for membrane proteins:
Genetic approaches:
Suppressor mutation analysis to identify compensatory mutations that restore function
Synthetic lethality screens to identify genes with redundant functions
Site-directed mutagenesis followed by functional complementation testing
Biochemical methods:
In vivo and in vitro crosslinking with bifunctional crosslinkers
Blue native PAGE to preserve native protein complexes
Co-immunoprecipitation with detergent-solubilized membranes
Surface plasmon resonance with reconstituted components
Structural techniques:
Cryo-electron microscopy of the assembled translocon
X-ray crystallography of stabilized complexes
Hydrogen-deuterium exchange mass spectrometry to map interaction surfaces
Disulfide mapping to identify proximity relationships
Live-cell imaging:
Fluorescence resonance energy transfer (FRET) between tagged components
Single-particle tracking to monitor dynamics
Super-resolution microscopy to visualize complex assembly
These approaches have revealed that SecE interacts not only with SecY and SecG, but also with accessory factors like YidC that assist in membrane protein integration . In V. cholerae, these interactions may be optimized for efficient secretion of virulence factors in pandemic strains compared to environmental isolates.
Isolation of functional SecYEG complexes requires careful optimization of multiple parameters:
Cell disruption: Gentle methods such as osmotic shock or freeze-thaw cycles better preserve complex integrity compared to sonication or high-pressure homogenization.
Membrane solubilization: Detergent selection is critical:
DDM (n-dodecyl β-D-maltoside): Effective but can destabilize peripheral interactions
LMNG (lauryl maltose neopentyl glycol): Better preserves complex integrity
Digitonin: Gentlest but less efficient solubilization
Optimal solubilization includes 1% detergent, 300 mM NaCl, and 10% glycerol at 4°C for 1 hour.
Purification strategy:
Affinity chromatography via His-tagged SecE or SecY
Ion exchange chromatography to separate intact complexes
Size exclusion chromatography as a final polishing step
Stabilization approaches:
Addition of lipids during purification (0.1 mg/ml E. coli lipid extract)
Reconstitution into nanodiscs or proteoliposomes for functional studies
Inclusion of substrate peptides to stabilize the active conformation
Quality control:
Blue native PAGE to verify complex integrity
SecA-stimulated ATPase activity assays to confirm functionality
Negative-stain electron microscopy to assess homogeneity
Researchers should note that SecYEG complexes from clinical V. cholerae isolates (particularly pandemic strains) may exhibit different stability properties compared to environmental isolates, potentially reflecting adaptations for efficient virulence factor secretion .
Studying essential genes like secE requires specialized CRISPR-Cas9 approaches since complete knockout is lethal. Optimal strategies include:
CRISPRi (interference) approach:
Use of catalytically dead Cas9 (dCas9) to repress rather than delete secE
Titration of guide RNA expression to achieve varying levels of repression
Inducible promoter systems to control timing of repression
Careful selection of guide RNA target sites to achieve partial repression
Conditional allele generation:
Creation of temperature-sensitive secE alleles for conditional inactivation
Incorporation of degron tags for inducible protein degradation
Introduction of modified secE under control of inducible promoters
Partial modification strategies:
Base editing to introduce specific point mutations without double-strand breaks
Prime editing for precise sequence changes without requiring homology-directed repair
Scarless genome editing using counterselectable markers
Screening considerations:
Use of fluorescent translocation reporters to monitor SecE function
High-throughput phenotypic assays sensitive to secretion defects
Careful control of growth conditions to reveal conditional phenotypes
V. cholerae-specific optimizations:
Codon optimization of Cas9/dCas9 for V. cholerae expression
Characterization of promoter activity in different V. cholerae strains
Consideration of strain-specific differences in DNA repair pathways
These approaches enable detailed study of secE function while maintaining sufficient activity for cell viability, revealing how specific regions contribute to translocon assembly, substrate recognition, and channel activity.
Investigating SecE's contribution to virulence factor secretion requires multifaceted experimental approaches:
Genetic manipulation strategies:
Construction of secE variants with domain swaps between pandemic and environmental strains
Site-directed mutagenesis of conserved residues with complementation testing
Creation of chimeric SecE proteins to identify regions critical for virulence factor secretion
Suppressor screens to identify compensatory mutations that restore function
Secretion assays:
Quantitative measurement of specific virulence factors in culture supernatants
Pulse-chase experiments to determine kinetics of protein secretion
Accumulation of secretory precursors in the cytoplasm or membrane
In vitro translocation assays with reconstituted components
Structural biology approaches:
Cryo-EM of the SecYEG complex with bound virulence factor precursors
Analysis of SecE conformational changes during translocation
Mapping interaction surfaces between SecE and substrate proteins
Virulence models:
Correlation of secretion defects with virulence in appropriate animal models
Competitive index assays comparing wild-type and secE mutants
Tissue culture infection models to assess delivery of secreted factors
Comparative genomics:
Analysis of secE sequence variations across V. cholerae lineages
Correlation of SecE variants with pandemic potential
Identification of co-evolving residues in SecE and virulence factors
These approaches have revealed that pandemic V. cholerae strains may possess optimized SecE variants that facilitate efficient secretion of key virulence factors, contributing to their pandemic potential .
The critical role of SecE in protein translocation makes it a potential target for antimicrobial development. Future research directions include:
High-resolution structural studies:
Cryo-EM structures of V. cholerae-specific SecYEG complexes
Comparison of conformational states during translocation
Identification of unique structural features in pandemic V. cholerae strains
Characterization of inhibitor binding sites
Inhibitor development:
Virtual screening against identified V. cholerae-specific features
Fragment-based drug discovery targeting the SecE-SecY interface
Peptidomimetic inhibitors based on substrate binding sites
Allosteric inhibitors that prevent conformational changes
Delivery mechanisms:
Conjugation to V. cholerae-specific targeting moieties
Packaging in nanoparticles for improved penetration
Combination approaches with membrane-permeabilizing agents
Validation approaches:
In vitro translocation inhibition assays
Cellular infection models
Animal models of cholera
Resistance development assessment
Translational potential:
Selectivity profiling against human Sec61 complex
Pharmacokinetic optimization for oral administration
Stability under conditions relevant to cholera treatment
These approaches could lead to novel therapeutics that specifically inhibit virulence factor secretion without disrupting beneficial gut microbiota, representing a targeted approach to cholera treatment .
Multiple cellular factors beyond the core SecYEG components influence translocation efficiency:
Membrane environment factors:
Lipid composition effects on SecYEG stability and function
Membrane fluidity changes during environmental adaptation
Membrane microdomain formation and SecYEG localization
Effects of cholesterol and other sterols on channel activity
Accessory proteins:
Role of SecDF in enhancing translocation efficiency
YidC cooperation in membrane protein integration
SecA ATPase activity regulation by cellular factors
Chaperone interactions that maintain substrate competence
Cellular energetics:
Proton motive force contributions to translocation
ATP availability under different growth conditions
Energy conservation mechanisms during stress
Regulatory mechanisms:
Transcriptional regulation of secE and other translocon components
Post-translational modifications affecting SecYEG function
Small RNA regulation of secretion machinery
Protein quality control systems that monitor SecYEG integrity
Strain-specific variations:
Comparative analysis of these factors between pandemic and environmental isolates
Identification of adaptations that enhance secretion in pathogenic strains
Co-evolution of regulatory networks with secretion machinery
Understanding these factors would provide deeper insights into how V. cholerae optimizes its secretion machinery during infection and environmental persistence, potentially revealing new therapeutic targets .